Erinaco was founded in 2016 by Maxim Kots to help pharmaceutical and medtech companies strengthen their clinical development and medical affairs capabilities.
We work as an external, flexible extension of your team – combining strategic insight with hands-on execution to advance products from concept to clinical practice.

Our expertise spans the full continuum of evidence generation and scientific engagement:

• Clinical development – design and optimisation of clinical development programmes and trials, from early-stage studies to late-phase and post-approval evidence.
• Medical affairs – planning and implementation of medical-education, publication, and KOL-engagement activities that turn data into actionable medical insight.
• Real-world evidence – development of pragmatic and regulatory-compliant RWE frameworks to complement traditional clinical data and support market access.
• Business development support – advisory input on portfolio evaluation, licensing opportunities, and cross-functional development planning.

Led by Maxim Kots – a life-science professional with two decades of international experience in clinical research and medical affairs – Erinaco unites a network of specialised partners to deliver tailored, high-quality support.

Our goal is simple: to bridge science and to bridge science and practice, helping new therapies reach patients with measurable value